NasdaqCM - Nasdaq Real Time Price USD

XTL Biopharmaceuticals Ltd. (XTLB)

Compare
1.0304
+0.0904
+(9.62%)
As of 11:39:29 AM EDT. Market Open.

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue --
Earnings --

Q2'15

Q3'15

Q4'15

Q1'16

0
 

Earnings Estimate

Currency in USD Current Qtr. (Jun 2016)Next Qtr. (Jan 1970)Current Year (2016)Next Year (1970)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS -0---0.04--

Revenue Estimate

Currency in USD Current Qtr. (Jun 2016)Next Qtr. (Jan 1970)Current Year (2016)Next Year (1970)
No. of Analysts --------
Avg. Estimate --------
Low Estimate --------
High Estimate --------
Year Ago Sales --------
Sales Growth (year/est) --------

Earnings History

Currency in USD 6/30/2015 9/30/2015 12/31/2015 3/31/2016
EPS Est. 0-0.0500
EPS Actual -0-0-0.01-0.01
Difference -0.010.05-0.02-0.01
Surprise % 0.00%90.00%0.00%0.00%

EPS Trend

Currency in USD Current Qtr. (Jun 2016)Next Qtr. (Jan 1970)Current Year (2016)Next Year (1970)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Jun 2016)Next Qtr. (Jan 1970)Current Year (2016)Next Year (1970)
Up Last 7 Days 1------
Up Last 30 Days 1------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
XTLB --------
S&P 500 6.68%6.74%9.91%14.34%

Upgrades & Downgrades

Initiated HC Wainwright & Co.: Buy 5/8/2015

Related Tickers